5ml semaglutide OL 12.5mg 2.5mg/ml x Semaglutide Injection 0.50 mg/0.5 ml

As Mounjaro usage continues to grow for both diabetes management and weight loss in the UK, increased awareness of this side effect will help patients prepare appropriately

Regarding the most likely etiology of our patients hemorrhage, elevated blood pressure on presentation along with CT- and catheter angiography showing no vascular malformation or aneurysm therefore makes hypertensive microangiopathy most likely

Health Canada Timeline Health Canada often reviews in parallel with the FDA and can approve a drug 6 to 12 months after US approval

GLP-1 Market Segmentation By Type of Molecule Outlook (Revenue, USD Billion, 20212034) Biologics Small Molecules By Active Compound Used Outlook (Revenue, USD Billion, 20212034) Dulaglutide Liraglutide Orforglipron Retatrutide Semaglutide Survodutide Tirzepatide Other Active Compounds By Type of GLP-1 Agonist Drugs Outlook (Revenue, USD Billion, 20212034) Long-acting GLP-1 Agonist Short-acting GLP-1 Agonist By Route of Administration Outlook (Revenue, USD Billion, 20212034) Oral Parenteral By Target Indication Outlook (Revenue, USD Billion, 20212034) Alzheimers Disease Non-Alcoholic Steatohepatitis Obesity Sleep Apnea Type 2 Diabetes By Regional Outlook (Revenue, USD Billion, 20212034) North America U.S